Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product & End-User The global ambulatory blood pressure monitoring devices market will witness a robust CAGR of 6.97%, valued at $110.46 million in 2021, expected to appreciate and reach $202.57 million by 2030, confirms Strategic Market Research. Ambulatory blood pressure monitoring devices measure blood pressure at regular intervals even when the patient is asleep. Estimations are that, at every (15 to 30) minute during the day and every (30 to 60) minute at night. A 24-hour ambulatory blood pressure monitoring device can detect and reduce white coat hypertension or masked hypertension so that people can timely receive the necessary treatments or medications required for high BP (Blood Pressure). According to CDC (Centres for Disease Control and Prevention), in 2017, high hypertension was regarded as blood pressure at or above 130/80 mmHg, whereas Stage 2 hypertension was defined as BP at or above 140/90 mmHg. Raised or high BP is responsible for approximately 7.6 million deaths each year, around 13.5% of the total number of deaths across the globe. Automated ambulatory blood pressure monitoring or Non-invasive Blood Pressure Monitoring provides either continuous or intermittent readings of BP. In the case of periodic non-invasive monitoring, and occluding upper arm cuff is most commonly used. The statistics mentioned above will positively impact the overall growth rate of the Market. The impact of COVID-19 on the Ambulatory Blood Pressure Monitoring Devices Market: The sudden outbreak of the COVID-19 pandemic has challenged the healthcare sector globally. Growing data shows that people with high BP are more prone to the risk of COVID-19 infections. A thorough analysis of data from both the USA and China showed that high BP is the most significant reason for hospitalized patients, which accounted for up to (30 to 50) % of the patients. High BP will, in turn, fuel the growth of the Market. Market Dynamics: - Market Drivers: Rising elderly population and an increase in the prevalence of hypertension (HTN) driving the growth of the market The rise in the geriatric population is one of the significant causes fuelling the growth of the Global Ambulatory Blood Pressure Monitoring Devices Market size. According to WHO, the ageing population worldwide is likely to reach approximately 2 billion by 2050 compared to 617 million in 2015. The rising prevalence of Hypertension (HTN) is also one of the significant causes driving the overall market growth. According to the NHANES (US National Health and Nutrition Examination Survey), 70% of adults over 65 years of age have hypertension and will have to take serious measures to reduce it. The above market drivers have led to the rise in usage of several ABPM devices such as The Welch Allyn ABPM, contec abpm50, tm 2430 blood pressure monitor, Oscar 2 ambulatory blood pressure monitor, Omron ambulatory blood pressure monitor, Holter bp monitor, space labs 90217 ABPM, etc. which is accelerating the overall market growth significantly. Restraints: Lack of clear reimbursement policies posing a major threat to the growth of the market Lack of reimbursement to the patients for using the ambulatory devices until and unless masked hypertension or white coat hypertension is suspected to be the primary factor restraining the market's growth. Opportunities: New Innovations in technology and the launch of new and affordable products in the market The Oscar 2 Ambulatory Blood Pressure Monitoring device has gained immense popularity in accurately measuring the blood pressure in patients and is likely to witness substantial growth in the future. Also, the Omron Ambulatory Blood Pressure Monitor is rapidly increasing as it comes with the TruRead technology for clinically accurate results. Thus, it is expected to grow at an exponential rate in the years to come. The ageing population and changing lifestyles demonstrate the greater adaptability of the ABPM Devices, thus providing a lucrative opportunity for growth. Also, the Healthcare Infrastructure and Healthcare expenditure has seen a massive uprise in the United States and other developing countries, which will create a good opportunity for substantial growth in the Ambulatory Blood Pressure Monitoring Devices Market during the forecasted period. Market Analysis Of Different Segments Covered in the Report Based on Product: Arm ABPM Devices Wrist ABPM Devices Based on End-User Hospitals Ambulatory Surgical Centers Others Regional Coverage Analysis North America US Mexico Canada Rest of North America Europe Spain Switzerland Russia Germany Netherlands U.K Finland Turkey France Belgium Italy Rest of Europe Asia Pacific China India Japan Malaysia Singapore Thailand Indonesia South Korea Philippines Australia Rest of Asia-Pacific LAMEA Argentina Brazil Uruguay Saudi Arabia Rest of LAMEA Product Analysis & Insights 'Arm ABPM Devices' dominated the market in 2021 with a steady CAGR due to its high availability and accuracy rate. As a result, they are more widely used globally than the Wrist ABPM Devices. They are more widely used globally than the Wrist ABPM Devices. End User Analysis & Insights The 'Hospitals' segment dominated the market with a consistent CAGR. The rising prevalence of BP and increase in government initiatives for developing the health care infrastructure to provide a better patient-centred care system are the major factors driving this market's growth. According to the US National Library of Medicine and National Institutes of Health, around 47% of coronary heart disease and 54% of stroke patients admitted to hospitals are prone to high BP. Regional Analysis & Insights 'North America' dominated the market based on region, covering approximately 42.25% of the total market share globally. An increase in overall health care expenditures is one of the leading causes propelling the overall market growth. Moreover, ABPM devices are affordable in the United States, ranging between USD 200 to USD 250. Also, according to CDC, in 2019, in the United States, high BP was the primary cause of mortality of 516,955 (i.e., 5.16 million) people. However, the 'Asia-Pacific' Region is the fastest-growing market region, with an overall CAGR of 8.75% throughout the forecasted period. Ambulatory Blood Pressure Monitoring Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 110.46 Million The revenue forecast in 2030 USD 202.57 Million Growth rate CAGR of approximately 6.97% The base year for estimation 2021 Historical data 2015 – 2019 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Type, By Application, By Region By Product Arm ABPM Devices, Wrist ABPM Devices By End-User Hospitals, Ambulatory Surgical Centers, Others By Region North America, Europe, Asia Pacific, LAMEA. Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Spacelabs Healthcare Inc, Bosch & Sohn GmbH & Co. KG, SunTech Medical, Schiller AG, Welch Allyn Inc, DAIFUKU CO. LTD, GE Company, Rudolf Riester GmbH, BPL Group, Mortara Instrument Inc., Vaso Corporation, Daray Medical, Microlife Corporation, Omron Healthcare Company. Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Global Ambulatory Blood Pressure Monitoring Devices Market Competitive Landscape Analysis Competitive landscape analysis is the most recommended technique to identify competitors in the market environment across the world accurately. Therefore, the comparison is performed exclusively based on market capability, global presence, market initiatives, expenditure in the field of R&D, overall revenue generated, production capacity, company overview and financials, production facilities and sites, organization flaws and strengths, etc. Spacelabs Healthcare Inc Bosch & Sohn GmbH & Co. KG SunTech Medical Schiller AG Welch Allyn Inc DAIFUKU CO. LTD GE Company Rudolf Riester GmbH BPL Group Mortara Instrument Inc. Vaso Corporation Daray Medical Microlife Corporation Omron Healthcare Company Recent Developments: - Recently, based on recommendations from the AHA and AMA, CMS expanded its national coverage of ABPM in 2 ways. The first one is lowering the (BP) threshold of hypertension from 140/90 to 130/80, thus allowing more patients to access ABPM. The second one is enabling the ABPM devices for those patients suspected of having lower-than-normal BP measurements in clinical tests. Schiller AG recently launched a PWA (Pulse-Wave Analysis Technique) that combines the cuff-based, non-invasive, oscillometric, and precise auscultatory measurement for generating a 24-hour profile of stiffness parameters like augmentation index, PWV (Pulse Wave Velocity), as well as peripheral and central BPs. Various Leading ABPM Devices that key Market Leaders Develop Name of the product Function Key Players Boso Medicus X Upper Arm Blood Pressure Monitoring Bosch & Sohn GmbH & Co. KG Sun Tech CT 40 Clinical-grade spot-check measurements of blood pressure SunTech Medical BP-200 Measuring and displaying a patient’s systolic and diastolic BPs at preset intervals Schiller AG FlexiPort Disposable Blood Pressure Cuffs Enhances patient safety and reduces the risk of cross-contamination Welch Allyn Inc Frequently Asked Question About This Report How Big is Ambulatory Blood Pressure Monitoring Devices Market? In 2021, the Global market share valuation was USD 110.46 million. It is predicted to reach USD 202.57 million by 2030 What was the market share in 2021? In 2021, the Global market share valuation was USD 110.46 million. It is predicted to reach USD 176.98 million by 2028, representing a CAGR of 6.97% throughout the forecasted period of 2021-2028. Who are the dominant players in the market? The key players in the market which driving the market are Spacelabs Healthcare Inc, Bosch & Sohn GmbH & Co. KG, SunTech Medical, Schiller AG, Welch Allyn Inc, DAIFUKU CO. LTD, GE Company, Rudolf Riester GmbH, BPL Group, Mortara Instrument Inc, Vaso Corporation, Daray Medical, Microlife Corporation, and Omron Healthcare Company. In 2021, which country accounted for the largest market share in the market? In 2021, the United States accounted for the largest market share in the market. What are the various blood pressure monitoring devices in the market? They are Welch Allyn ABPM, contec abpm50, tm 2430 blood pressure monitor, Oscar 2 ambulatory blood pressure monitor, Omron ambulatory blood pressure monitor, Holter bp monitor, spacelabs 90217 ABPM, etc. Which is the leading product segment in the market? Arm ABPM Devices is the leading product segment in the market. Which is the most dominant and leading End User segment in the market? The Hospitals segment is the most dominant and leading End User segment in the market. Which geographical region has the largest share in the market? North America has the largest share in the market, covering up to 42.25% of the total market share and will continue to dominate the market over the forecasted period of 2021-2030. Sources https://www.cdc.gov/bloodpressure/facts.htm https://www.who.int/news-room/fact-sheets/detail/ageing-and-health https://www.cdc.gov/nchs/data/factsheets/factsheet_nhanes.pdf https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059018/ Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Market Segmentation 1.3.2 Geographic Scope Figure 02: Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Market, 2021–2030 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Market, 2021–2030 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Market, 2021–2030(USD Million) 3.1.4 Market Summary Figure 010: Arm ABPM Devices to Witness Highest CAGR in Market, By Type, During Forecast Period Figure 11: Hospitals Higher CAGR in Market for Application Segment during Forecast Period Figure 12: North America to Account for Largest Share of Global Market In 2021 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 13: Market Segmentation Chapter 5. Industry Outlook 5.1 Ambulatory Blood Pressure Monitoring Devices Market Snapshot 5.2 Global Market 5.2.1 Global Market, 2021 – 2030 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global Market, by region, 2021 - 2030 (USD Million) 5.4 Type Segment Analysis 5.4.1 Global Market, by Type, 2021 - 2030 (USD Million) 5.5 Application Segment Analysis 5.5.1 Global Market, By Application, 2021 - 2030 (USD Million) 5.6 Value Chain Analysis 5.7 Market Variable Analysis 5.7.1 Market Drivers Analysis 5.7.2 Market Restraints Analysis 5.8 Business Environment Analysis Tool 5.8.1 Market PEST analysis 5.8.2 Market Porter’s analysis 5.9 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 14 Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 15 Market Drivers and Their Impact 6.2.2 Restraints Figure 16 Market Restraints and Their Impact 6.2.3 Opportunities Figure 17 Market Opportunities and Their Impact 6.2.4 Challenges Figure 18 Market Challenges and Their Impact 6.3 Impact of Covid-19 on Market 6.4 Value Chain Analysis Figure 19 Value Chain Analysis: Market 6.5 Ecosystem Figure 20 Market: Ecosystem Table 3 Market: Ecosystem Figure 21 Revenue Shift in Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Market in USA in Last 9 Years Figure 22 Top 14 Companies with Highest No. of Patents in Last 9 Years Figure 23 No of Patents Granted Per Year, 2019–2021 Table 5 List of Global Patents in Market 6.7 Trade Analysis Figure 24 Import Data for Arm ABPM Devices, By Country, 2016–2021 (USD Thousand) Table 6 Import Data for Wrist ABPM Devices, By Country, 2016–2021 (USD Thousand) Figure 25 Export Data for Arm ABPM Devices, By Country, 2016–2021 (USD Thousand) Table 7 Export Data for Wrist ABPM Devices, By Country, 2016–2021 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 8 Market: Porter’s Five Forces Analysis, 2021 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2021) 6.11.2 Trends in Technology (2021-2030) Table 9 Key Regulations: Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 10: Key Players market share Figure 26: Key players market share of companies 7.2 Manufacturers Ambulatory Blood Pressure Monitoring Devices Manufacturing Sites, Area Served, Product Type 7.3 Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Market: Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2021-2030) Table 11 Market, By Type, 2021–2030 (USD Million) Figure 27 Market, By Type Figure 28 Arm ABPM Devices Segment to Register Highest CAGR in Market During Forecast Period 8.3 Arm ABPM Devices 8.3.1 Arm ABPM Devices market, 2021 - 2030 (USD Million) Figure 29: Arm ABPM Devices market, 2021 - 2030 (USD Million) 8.4 Wrist ABPM Devices 8.4.1 Wrist ABPM Devices market, 2021 - 2030 (USD Million) Figure 30: Wrist ABPM Devices market, 2021 - 2030 (USD Million) Chapter 9. Global Market: Application Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2021-2030) Table 12: Market, By Application, 2021–2030 (USD Million) Figure 31: Market, By Application, 2021–2030 (USD Million) Figure 32: Hospitals Segment to Register Highest CAGR in Market during Forecast Period 9.3 Hospitals 9.3.1 Hospitals market, 2021 - 2030 (USD Million) Figure 33: Hospitals market, 2021 - 2030 (USD Million) 9.4 Ambulatory Surgical Centers 9.4.1 Ambulatory Surgical Centers market, 2021 - 2030 (USD Million) Figure 34: Ambulatory Surgical Centers market, 2021 - 2030 (USD Million) 9.5 Others 9.5.1 Others market, 2021 - 2030 (USD Million) Figure 35: Others market, 2021 - 2030 (USD Million) Chapter 10. Global Market: Regional Outlook 10.1 North America Figure 36: North America Market, By Revenue Forecast (2021-2030) 10.1.1 North America Market, by country, 2021 - 2030 (USD Million) Table 13: North America Market, by Country, 2021-2030 Figure 37: North America Market 10.1.2 North America Market, by Type, 2021 - 2030 (USD Million) Table14: North America Market, by Type, 2021 - 2030 (USD Million) Figure 38: North America Market, by Type, 2021 - 2030 (USD Million) 10.1.3 North America Market, by Application, 2021 - 2030 (USD Million) Table 15: North America Market, by Application, 2021 - 2030 (USD Million) Figure 39: North America Market, by Application, 2021 - 2030 (USD Million) 10.1.4 U.S. 10.1.4.1 U.S. Market, by Type, 2021 - 2030 (USD Million) Figure 40: U.S. Market, by Type, 2021 - 2030 (USD Million) 10.1.4.2 U.S. Market, by Application, 2021 - 2030 (USD Million) Figure 41: U.S. Market, by Application, 2021 - 2030 (USD Million) 10.1.5 Canada 10.1.5.1 Canada Market, by Type, 2021 - 2030 (USD Million) Figure 42: Canada Market, by Type, 2021 - 2030 (USD Million) 10.1.5.2 Canada Market, by Application, 2021 - 2030 (USD Million) Figure 43: Canada Market, by Application, 2021 - 2030 (USD Million) Figure 44: Canada Market, by Application, 2021 - 2030 (USD Million) Figure 45: Canada Market, by Application, 2021 - 2030 (USD Million) 10.2 Europe Figure 46: Europe Market, By Revenue Forecast (2021-2030) 10.2.1 Europe Market, by country, 2021 - 2030 (USD Million) Table 16: Europe Market, by country, 2021 - 2030 (USD Million) Figure 47: Europe Market, by country, 2021 - 2030 (USD Million) 10.2.2 Europe Market, by Type, 2021 - 2030 (USD Million) Table 17: Europe Market, by Type, 2021 - 2030 (USD Million) Figure 48: Europe Market, by Type, 2021 - 2030 (USD Million) 10.2.3 Europe Market, by Application, 2021 - 2030 (USD Million) Table 18: Europe Market, by Application, 2021 - 2030 (USD Million) Figure 49: Europe Market, by Application, 2021 - 2030 (USD Million) 10.2.4 U.K. 10.2.4.1 U.K. Market, by Type, 2021 - 2030 (USD Million) Figure 50: U.K. Market, by Type, 2021 - 2030 (USD Million) 10.2.4.2 U.K. Market, by Application, 2021 - 2030 (USD Million) Figure 51: U.K. Market, by Application, 2021 - 2030 (USD Million) 10.2.5 Germany 10.2.5.1 Germany Market, by Type, 2021 - 2030 (USD Million) Figure 52: Germany Market, by Type, 2021 - 2030 (USD Million) 10.2.5.2 Germany Market, by Application, 2021 - 2030 (USD Million) Figure 53: Germany Market, by Application, 2021 - 2030 (USD Million) 10.2.6 France 10.2.6.1 France Market, by Type, 2021 - 2030 (USD Million) Figure 54: France Market, by Type, 2021 - 2030 (USD Million) 10.2.6.2 France Market, by Application, 2021 - 2030 (USD Million) Figure 55: France Market, by Application, 2021 - 2030 (USD Million) 10.2.7 Rest of Europe 10.2.7.1 Rest of Europe Market, by Type, 2021 - 2030 (USD Million) Figure 56: Rest of Europe Market, by Type, 2021 - 2030 (USD Million) 10.2.7.2 Rest of Europe Market, by Application, 2021 - 2030 (USD Million) Figure 57: Rest of Europe Market, by Application, 2021 - 2030 (USD Million) 10.3 Asia Pacific Figure 58: Asia Pacific Market, By Revenue Forecast (2021-2030) 10.3.1 Asia Pacific Market, by country, 2021 - 2030 (USD Million) Table 19: Asia Pacific Market, by country, 2021 - 2030 (USD Million) Figure 59: Asia Pacific Market, by country, 2021 - 2030 (USD Million) 10.3.2 Asia Pacific Market, by Type, 2021 - 2030 (USD Million) Table 20: Asia Pacific Market, by Type, 2021 - 2030 (USD Million) Figure 60: Asia Pacific Market, by Type, 2021 - 2030 (USD Million) 10.3.3 Asia Pacific Market, by Application, 2021 - 2030 (USD Million) Table 21: Asia Pacific Market, by Application, 2021 - 2030 (USD Million) Figure 61: Asia Pacific Market, by Application, 2021 - 2030 (USD Million) 10.3.4 China 10.3.4.1 China Market, by Type, 2021 - 2030 (USD Million) Figure 62: China Market, by Type, 2021 - 2030 (USD Million) 10.3.4.2 China Market, by Application, 2021 - 2030 (USD Million) Figure 63: China Market, by Application, 2021 - 2030 (USD Million) 10.3.5 India 10.3.5.1 India Market, by Type, 2021 - 2030 (USD Million) Figure 64: India Market, by Type, 2021 - 2030 (USD Million) 10.3.5.2 India Market, by Application, 2021 - 2030 (USD Million) Figure 65: India Market, by Application, 2021 - 2030 (USD Million) 10.3.6 Japan 10.3.6.1 Japan Market, by Type, 2021 - 2030 (USD Million) Figure 66: Japan Market, by Type, 2021 - 2030 (USD Million) 10.3.6.2 Japan Market, by Application, 2021 - 2030 (USD Million) Figure 67: Japan Market, by Application, 2021 - 2030 (USD Million) 10.3.7 South Korea 10.3.7.1 South Korea Market, by Type, 2021 - 2030 (USD Million) Figure 68: South Korea Market, by Type, 2021 - 2030 (USD Million) 10.3.7.2 South Korea Market, by Application, 2021 - 2030 (USD Million) Figure 69: South Korea Market, by Application, 2021 - 2030 (USD Million) 10.3.8 Rest of APAC 10.3.8.1 Rest of APAC Market, by Type, 2021 - 2030 (USD Million) Figure 70: Rest of APAC Market, by Type, 2021 - 2030 (USD Million) 10.3.8.2 Rest of APAC Market, by Application, 2021 - 2030 (USD Million) Figure 71: Rest of APAC Market, by Application, 2021 - 2030 (USD Million) 10.4 Latin America Figure 72: Latin America Market, By Revenue Forecast (2021-2030) 10.4.1 Latin America Market, by country, 2021 - 2030 (USD Million) Table 22: Latin America Market, by country, 2021 - 2030 (USD Million) Figure 73: Latin America Market, by country, 2021 - 2030 (USD Million) 10.4.2 Latin America Market, by Type, 2021 - 2030 (USD Million) Table 23: Latin America Market, by Type, 2021 - 2030 (USD Million) Figure 74: Latin America Market, by Type, 2021 - 2030 (USD Million) 10.4.3 Latin America Market, by Application, 2021 - 2030 (USD Million) Table 24: Latin America Market, by Application, 2021 - 2030 (USD Million) Figure 75: Latin America Market, by Application, 2021 - 2030 (USD Million) 10.4.4 Brazil 10.4.4.1 Brazil Market, by Type, 2021 - 2030 (USD Million) Figure 76: Brazil Market, by Type, 2021 - 2030 (USD Million) 10.4.4.2 Brazil Market, by Application, 2021 - 2030 (USD Million) Figure 77: Brazil Market, by Application, 2021 - 2030 (USD Million) 10.4.5 Mexico 10.4.5.1 Mexico Market, by Type, 2021 - 2030 (USD Million) Figure 78: Mexico Market, by Type, 2021 - 2030 (USD Million) 10.4.5 2 Mexico Market, by Application, 2021 - 2030 (USD Million) Figure 79: Mexico Market, by Application, 2021 - 2030 (USD Million) 10.4.6 Rest of Latin America 10.4.6.1 Rest of the Latin America Market, by Type, 2021 - 2030 (USD Million) Figure 80: Rest of the Latin America Market, by Type, 2021 - 2030 (USD Million) 10.4.6.2 Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) Figure 81: Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) 10.5 MEA Figure 82: MEA Market, By Revenue Forecast (2021-2030) 10.5.1 MEA Market, by Type, 2021 - 2030 (USD Million) Figure 83: MEA Market, by Type, 2021 - 2030 (USD Million) 10.5.2 MEA Market, by Application, 2021 - 2030 (USD Million) Figure 84: MEA Market, by Application, 2021 - 2030 (USD Million) Chapter 11. Competitive Landscape 11.1 Spacelabs Healthcare Inc. 11.1.1 Company overview 11.1.2 Financial performance 11.1.3 Product Portfolio Analysis 11.1.4 Business Strategy & Recent Development 11.2 Bosch & Sohn GmbH & Co. KG. 11.2 .1 Company overview 11.2 .2 Financial performance 11.2 .3 Product Portfolio Analysis 11.2 .4 Business Strategy & Recent Development 11.3 SunTech Medical. 11.3.1 Company overview 11.3.2 Financial performance 11.3.3 Product Portfolio Analysis 11.3.4 Business Strategy & Recent Development 11.4 Schiller AG. 11.4.1 Company overview 11.4.2 Financial performance 11.4.3 Product Portfolio Analysis 11.4.4 Business Strategy & Recent Development 11.5 Welch Allyn Inc. 11.5.1 Company overview 11.5.2 Financial performance 11.5.3 Product Portfolio Analysis 11.5.4 Business Strategy & Recent Development 11.6 DAIFUKU CO. LTD. 11.6.1 Company overview 11.6.2 Financial performance 11.6.3 Product Portfolio Analysis 11.6.4 Business Strategy & Recent Development 11.7 GE Company. 11.7.1 Company overview 11.7.2 Financial performance 11.7.3 Product Portfolio Analysis 11.7.4 Business Strategy & Recent Development 11.8 Rudolf Riester GmbH. 11.8.1 Company overview 11.8.2 Financial performance 11.8.3 Product Portfolio Analysis 11.8.4 Business Strategy & Recent Development 11.9 BPL Group. 11.9.1 Company overview 11.9.2 Financial performance 11.9.3 Product Portfolio Analysis 11.9.4 Business Strategy & Recent Development 11.10 Mortara Instrument Inc. 11.10.1 Company overview 11.10.2 Financial performance 11.10.3 Product Portfolio Analysis 11.10.4 Business Strategy & Recent Development 11.11 Vaso Corporation. 11.11.1 Company overview 11.11.2 Financial performance 11.11.3 Product Portfolio Analysis 11.11.4 Business Strategy & Recent Development 11.12 Daray Medical. 11.12.1 Company overview 11.12.2 Financial performance 11.12.3 Product Portfolio Analysis 11.12.4 Business Strategy & Recent Development 11.13 Microlife Corporation. 11.13.1 Company overview 11.13.2 Financial performance 11.13.3 Product Portfolio Analysis 11.13.4 Business Strategy & Recent Development 11.14 Omron Healthcare Company. 11.14.1 Company overview 11.14.2 Financial performance 11.14.3 Product Portfolio Analysis 11.14.4 Business Strategy & Recent Development